Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 12

1.

Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.

Raspotnig M, Haugen M, Thorsteinsdottir M, Stefansson I, Salvesen HB, Storstein A, Vedeler CA.

Cancer Immunol Immunother. 2017 Nov;66(11):1463-1471. doi: 10.1007/s00262-017-2041-8. Epub 2017 Jul 14.

PMID:
28710511
2.

Proteolytic degradation and potential role of onconeural protein cdr2 in neurodegeneration.

Hwang JY, Lee J, Oh CK, Kang HW, Hwang IY, Um JW, Park HC, Kim S, Shin JH, Park WY, Darnell RB, Um HD, Chung KC, Kim K, Oh YJ.

Cell Death Dis. 2016 Jun 2;7(6):e2240. doi: 10.1038/cddis.2016.151.

3.

Onconeuronal antigen Cdr2 correlates with HIF prolyl-4-hydroxylase PHD1 and worse prognosis in renal cell carcinoma.

Kaufmann MR, Schraml P, Hermanns T, Wenger RH, Camenisch G.

Exp Mol Pathol. 2013 Jun;94(3):453-7. doi: 10.1016/j.yexmp.2013.03.005. Epub 2013 Mar 24.

PMID:
23531419
4.

Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.

Rojas-Marcos I, Picard G, Chinchón D, Gelpi E, Psimaras D, Giometto B, Delattre JY, Honnorat J, Graus F.

Neuro Oncol. 2012 Apr;14(4):506-10. doi: 10.1093/neuonc/nos006. Epub 2012 Feb 20.

5.

CDR2 antigen and Yo antibodies.

Totland C, Aarskog NK, Eichler TW, Haugen M, Nøstbakken JK, Monstad SE, Salvesen HB, Mørk S, Haukanes BI, Vedeler CA.

Cancer Immunol Immunother. 2011 Feb;60(2):283-9. doi: 10.1007/s00262-010-0943-9. Epub 2010 Nov 16.

6.

Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.

Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR.

Mol Med. 2010 Jul-Aug;16(7-8):247-53. doi: 10.2119/molmed.2009.00159. Epub 2010 Mar 17. Erratum in: Mol Med. 2012;18(1):729.

7.

Antibody to CCDC104 is associated with a paraneoplastic antibody to CDR2 (anti-Yo).

Totland C, Bredholt G, Haugen M, Haukanes BI, Vedeler CA.

Cancer Immunol Immunother. 2010 Feb;59(2):231-7. doi: 10.1007/s00262-009-0742-3.

PMID:
19680650
8.

Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.

Balamurugan K, Luu VD, Kaufmann MR, Hofmann VS, Boysen G, Barth S, Bordoli MR, Stiehl DP, Moch H, Schraml P, Wenger RH, Camenisch G.

Oncogene. 2009 Sep 17;28(37):3274-85. doi: 10.1038/onc.2009.186. Epub 2009 Jul 6.

PMID:
19581925
11.
12.

Tumor-specific killer cells in paraneoplastic cerebellar degeneration.

Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB.

Nat Med. 1998 Nov;4(11):1321-4.

PMID:
9809559

Supplemental Content

Support Center